Compounds > emtricitabine
Page last updated: 2024-08-24

emtricitabine and resveratrol

emtricitabine has been researched along with resveratrol in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Bonnac, L; Clouser, CL; Daly, MB; Kim, B; Landman, SR; Mansky, LM; Patterson, SE; Rawson, JM; Reilly, CS; Roth, ME; Xie, J1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Amin, MN; Davis, C; Deeks, SG; Heredia, A; Le, NM; Oliveira, M; Redfield, RR; Wainberg, MA; Wang, LX1

Other Studies

3 other study(ies) available for emtricitabine and resveratrol

ArticleYear
Synergistic reduction of HIV-1 infectivity by 5-azacytidine and inhibitors of ribonucleotide reductase.
    Bioorganic & medicinal chemistry, 2016, 06-01, Volume: 24, Issue:11

    Topics: Anti-HIV Agents; Azacitidine; Dose-Response Relationship, Drug; Enzyme Inhibitors; HIV Infections; HIV-1; Humans; Microbial Sensitivity Tests; Molecular Structure; Ribonucleotide Reductases; Structure-Activity Relationship

2016
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Targeting host nucleotide biosynthesis with resveratrol inhibits emtricitabine-resistant HIV-1.
    AIDS (London, England), 2014, Jan-28, Volume: 28, Issue:3

    Topics: Anti-HIV Agents; Cells, Cultured; Deoxycytidine; Drug Resistance, Viral; Emtricitabine; Enzyme-Linked Immunosorbent Assay; HIV Core Protein p24; HIV Reverse Transcriptase; HIV-1; Humans; Lymphocytes; Mutation, Missense; Real-Time Polymerase Chain Reaction; Resveratrol; Stilbenes; Virus Replication

2014